benzylphosphonic acid has been researched along with 2,6-diaminopyridine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burilov, A; Gibadullina, E; Nguyen, TT; Pudovik, M; Sapunova, A; Strelnik, A; Sudakov, I; Voloshina, A; Voronina, J; Vyshtakalyuk, A | 1 |
1 other study(ies) available for benzylphosphonic acid and 2,6-diaminopyridine
| Article | Year |
|---|---|
New 2,6-diaminopyridines containing a sterically hindered benzylphosphonate moiety in the aromatic core as potential antioxidant and anti-cancer drugs.
Topics: Amidines; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Aspergillus niger; Bacillus cereus; Candida albicans; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Escherichia coli; HeLa Cells; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Molecular Structure; Organophosphonates; Pseudomonas aeruginosa; Pyridines; Staphylococcus aureus; Structure-Activity Relationship | 2019 |